254 related articles for article (PubMed ID: 27158798)
21. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
[TBL] [Abstract][Full Text] [Related]
22. Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis.
Yu Y; Chen Z; Wang Y; Li Y; Lu J; Cui L; Yu Z; Ding Y; Guo C; Zhang X; Shi Y
Int Immunopharmacol; 2021 Jul; 96():107722. PubMed ID: 33965878
[TBL] [Abstract][Full Text] [Related]
23. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis.
Ye LL; Peng WB; Niu YR; Xiang X; Wei XS; Wang ZH; Wang X; Zhang SY; Chen X; Zhou Q
Ann Transl Med; 2020 Dec; 8(24):1647. PubMed ID: 33490159
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
[TBL] [Abstract][Full Text] [Related]
25. Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients.
Engku Abd Rahman ENS; Irekeola AA; Shueb RH; Mat Lazim N; Mohamud R; Chen X; Ghazali L; Awang NMSH; Haron A; Chan YY
Cytokine; 2023 Oct; 170():156341. PubMed ID: 37657236
[TBL] [Abstract][Full Text] [Related]
26. TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.
Chen X; Oppenheim JJ
Curr Dir Autoimmun; 2010; 11():119-34. PubMed ID: 20173391
[TBL] [Abstract][Full Text] [Related]
27. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2.
Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z
J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122
[TBL] [Abstract][Full Text] [Related]
28. Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.
Torrey H; Butterworth J; Mera T; Okubo Y; Wang L; Baum D; Defusco A; Plager S; Warden S; Huang D; Vanamee E; Foster R; Faustman DL
Sci Signal; 2017 Jan; 10(462):. PubMed ID: 28096513
[TBL] [Abstract][Full Text] [Related]
29. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
[TBL] [Abstract][Full Text] [Related]
30. Lack of association between tumour necrosis factor receptor types 1 and 2 gene polymorphism and severe acute alcoholic hepatitis.
Nguyen-Khac E; Houchi H; Daoust M; Dupas JL; Naassila M
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):794-800. PubMed ID: 19641466
[TBL] [Abstract][Full Text] [Related]
31. TNFR2-expressing CD4
He J; Li R; Chen Y; Hu Y; Chen X
Prog Mol Biol Transl Sci; 2019; 164():101-117. PubMed ID: 31383403
[TBL] [Abstract][Full Text] [Related]
32. Targeted killing of TNFR2-expressing tumor cells and T
Torrey H; Khodadoust M; Tran L; Baum D; Defusco A; Kim YH; Faustman DL
Leukemia; 2019 May; 33(5):1206-1218. PubMed ID: 30356161
[TBL] [Abstract][Full Text] [Related]
33. Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function.
Housley WJ; Adams CO; Nichols FC; Puddington L; Lingenheld EG; Zhu L; Rajan TV; Clark RB
J Immunol; 2011 Jun; 186(12):6779-87. PubMed ID: 21572024
[TBL] [Abstract][Full Text] [Related]
34. Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.
Salomon BL; Leclerc M; Tosello J; Ronin E; Piaggio E; Cohen JL
Front Immunol; 2018; 9():444. PubMed ID: 29593717
[TBL] [Abstract][Full Text] [Related]
35. MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2.
Jiang M; Yang Y; Niu L; Li P; Chen Y; Liao P; Wang Y; Zheng J; Chen F; He H; Li H; Chen X
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36319063
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab.
Crommelin HA; van der Burg LM; Vorselaars AD; Drent M; van Moorsel CH; Rijkers GT; Deneer VH; Grutters JC
Respir Med; 2016 Jun; 115():72-7. PubMed ID: 27215507
[TBL] [Abstract][Full Text] [Related]
37. An alternatively spliced soluble TNF-alpha receptor is associated with metabolic disorders: a replication study.
Fernández-Real JM; Botas-Cervero P; Lainez B; Ricart W; Delgado E
Clin Immunol; 2006 Nov; 121(2):236-41. PubMed ID: 16979382
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a TNFR2-Selective Agonistic TNF-α Mutant and Its Derivatives as an Optimal Regulatory T Cell Expander.
Inoue M; Yamashita K; Tsuji Y; Miki M; Amano S; Okumura T; Kuge K; Tone T; Enomoto S; Yoshimine C; Morita Y; Ando D; Kamada H; Mikami N; Tsutsumi Y; Tsunoda SI
J Immunol; 2021 Apr; 206(8):1740-1751. PubMed ID: 33782090
[TBL] [Abstract][Full Text] [Related]
39. Bivalent structure of a TNFR2-selective and agonistic TNF-α mutein Fc-fusion protein enhances the expansion activity of regulatory T cells.
Inoue M; Tsuji Y; Ueno R; Miyamoto D; Tanaka K; Moriyasu Y; Shibata S; Okuda M; Ando D; Abe Y; Kamada H; Tsunoda SI
Sci Rep; 2023 Aug; 13(1):13762. PubMed ID: 37612373
[TBL] [Abstract][Full Text] [Related]
40. Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity.
Chen Y; Jia M; Wang S; Xu S; He N
Front Immunol; 2022; 13():835690. PubMed ID: 35251028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]